TB 500, also known as Thymosin Beta-4, is a peptide composed of 43 amino acids. It plays a crucial role in various physiological processes in the human body, particularly in muscle recovery. TB 500 was initially isolated from thymus tissue, and research has shown that it has important regulatory functions in cell migration, angiogenesis, and tissue repair.
In recent years, with the deepening of research into the pathogenesis of metabolic diseases, the development of multi-target agonist drugs targeting multiple hormone receptors has become a hot topic. GLP-3 is a novel triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GC) receptors.
Mazdutide is a novel drug that acts as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors. GLP-1 and glucagon receptors play important roles in metabolic regulation in the human body.
Chronic nonbacterial prostatitis is a common urological condition. Prostamax, a novel therapeutic agent associated with bioactive peptides, plays a role in maintaining prostate health. In the treatment of experimental chronic nonbacterial prostatitis, Prostamax has demonstrated positive effects.
Thymosin Alpha-1 (Tα1) is a highly conserved polypeptide composed of 28 amino acids that plays a critical role in immune regulation within the body.
